QuidelOrtho Overview
- Year Founded
-
1979
- Status
-
Public
- Employees
-
6,500
- Stock Symbol
-
QDEL
- Investments
-
14
- Share Price
-
$10.74
- (As of Friday Closing)
QuidelOrtho General Information
Description
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Contact Information
Website
www.quidelortho.comCorporate Office
- 9975 Summers Ridge Road
- San Diego, CA 92121
- United States
Corporate Office
- 9975 Summers Ridge Road
- San Diego, CA 92121
- United States
QuidelOrtho Timeline
QuidelOrtho Stock Performance
As of 13-Nov-2026, QuidelOrtho’s stock price is $10.74. Its current market cap is $737M with 68.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.74 | $10.62 | $9.92 - $35.58 | $737M | 68.6M | 1.9M | -$5.41 |
QuidelOrtho Financials Summary
As of 30-Sep-2026, QuidelOrtho has a trailing 12-month revenue of $2.59B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,674,785 | 4,685,825 | 5,608,287 | 7,401,140 |
| Revenue | 2,593,200 | 2,730,200 | 2,782,900 | 2,997,800 |
| EBITDA | 324,300 | (484,800) | (1,492,400) | 601,500 |
| Net Income | (369,200) | (1,131,800) | (2,052,000) | (10,100) |
| Total Assets | 5,781,300 | 5,769,300 | 6,423,600 | 8,563,100 |
| Total Debt | 3,116,300 | 2,833,900 | 2,681,400 | 2,614,100 |
QuidelOrtho Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
QuidelOrtho Comparisons
Industry
Financing
Details
QuidelOrtho Competitors (15)
One of QuidelOrtho’s 15 competitors is Revvity, a Corporation company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Revvity | Corporation | Waltham, MA | ||||
| Diasorin | Formerly PE-Backed | Saluggia, Italy | ||||
| Randox Laboratories | Corporation | Crumlin, United Kingdom | ||||
| Hologic | Private Equity-Backed | Marlborough, MA | ||||
| Great Basin Scientific | Formerly VC-backed | West Valley City, UT |
QuidelOrtho Patents
QuidelOrtho Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024192043-A1 | Security protection for medical devices | Inactive | 13-Mar-2023 | ||
| WO-2024151998-A2 | Image capturing and processing for immunoassays | Inactive | 13-Jan-2023 | ||
| WO-2024151998-A3 | Image capturing and processing for immunoassays | Inactive | 13-Jan-2023 | ||
| EP-4605746-A1 | Devices and kits for detecting analytes of interest and methods of using the same | Pending | 20-Oct-2022 | ||
| US-20240133881-A1 | Devices and kits for detecting analytes of interest and methods of using the same | Pending | 20-Oct-2022 | G01N33/558 |
QuidelOrtho Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
QuidelOrtho Investments & Acquisitions (14)
QuidelOrtho’s most recent deal was a Merger/Acquisition with LEX Diagnostics for . The deal was made on 17-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| LEX Diagnostics | 17-Apr-2026 | Merger/Acquisition | Diagnostic Equipment | ||
| LEX Diagnostics | 01-Dec-2023 | Corporate | Diagnostic Equipment | ||
| Developer and Manufacturer of Assays (QuidelOrtho / Shanghai Runda Medical Technology Company) | 29-Jul-2022 | Joint Venture | Diagnostic Equipment | ||
| Ortho-Clinical Diagnostics | 27-May-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| JRNYS | 10-Sep-2021 | Later Stage VC | Outcome Management (Healthcare) |
QuidelOrtho ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
QuidelOrtho Exits (1)
QuidelOrtho’s most recent exit was on 12-Apr-2002 from CymaBay Therapeutics. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CymaBay Therapeutics | 12-Apr-2002 | Completed |
|
QuidelOrtho Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Quidelortho Sales Company | San Diego, CA | 2024 | |
| Orca Holdco 2 | Raritan, NJ | 2021 | |
| LEX Diagnostics | Melbourn, United Kingdom | 2020 | |
| QuidelOrtho (Transfusion Medicine Unit) | San Diego, CA |
QuidelOrtho FAQs
-
When was QuidelOrtho founded?
QuidelOrtho was founded in 1979.
-
Where is QuidelOrtho headquartered?
QuidelOrtho is headquartered in San Diego, CA.
-
What is the size of QuidelOrtho?
QuidelOrtho has 6,500 total employees.
-
What industry is QuidelOrtho in?
QuidelOrtho’s primary industry is Diagnostic Equipment.
-
Is QuidelOrtho a private or public company?
QuidelOrtho is a Public company.
-
What is QuidelOrtho’s stock symbol?
The ticker symbol for QuidelOrtho is QDEL.
-
What is the current stock price of QuidelOrtho?
As of 13-Nov-2026 the stock price of QuidelOrtho is $10.74.
-
What is the current market cap of QuidelOrtho?
The current market capitalization of QuidelOrtho is $737M.
-
What is QuidelOrtho’s current revenue?
The trailing twelve month revenue for QuidelOrtho is $2.59B.
-
Who are QuidelOrtho’s competitors?
Revvity, Diasorin, Randox Laboratories, Hologic, and Great Basin Scientific are some of the 15 competitors of QuidelOrtho.
-
What is QuidelOrtho’s annual earnings per share (EPS)?
QuidelOrtho’s EPS for 12 months was -$5.41.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
